chrisvoncsefalvay/vaers-outcomes huggingface dataset:
UTI with extreme pain; UTI with extreme pain; have issues with emptying bladder; worst insomnia; IBS and SIBO both these conditions were worse starting about five days after the second vaccine; IBS and SIBO both these conditions were worse starting about five days after the second vaccine; I have IBS and SIBO both these conditions were worse starting about five days after the second vaccine; nauseous; had no appetite; lost about twelve pounds; This is a spontaneous report received from a contactable consumer. This consumer reported for her sister and stated that, a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient experienced uti with extreme pain, have issues with emptying bladder, worst insomnia, ibs and sibo both these conditions were worse starting about five days after the second vaccine, nauseous, had no appetite and lost about twelve pounds on an unspecified date. The consumer also went through the same thing after her second covid shot. Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : PFIZER INC-202100969975 same reporter/product/event, different patient; PFIZER INC-202100973724 same reporter, different patient/ product/ event.
Day one first hour- sore and inflamed arm, Headache Day one over night - chills,  Day 2 and Day 3 - really sore and inflamed arm, chills, night sweats, loss of appetite, fatigue
fever 100-3hr p/vax;both arms very swollen;fever 102 (4 days later) 9MAR98 seen by MD unable to move lt shoulder w/severe pain to lt neck;referred to MD;impression local rxn to lt arm inc deltoid & trapezoid noted brachial nerve involvement
Pt's  mom called and says that expierenced pain and some swelling at site of injection as well as fever (?), headache, tiredness, chills, body aches and rash at site. Mom has been alternating Tylenol and Motrin without relief.  One day after the vaccine pt.c/o some tightness in her chest and mom gave her albuterol (pt. also an asthmatic)Mom says that was getting more and more stressed which may have caused the tightness in her chest. Mom gave her Benadryl at HS.Today (2 days after vaccine) still c/o the same symptons (headache and body aches) Advised to go to PCP for evaluation of symptoms.  Mom says that she is driving to college today and if her symptoms persist she will take her to the doctor on the campus.
In the week following my 2nd vaccine, I started to feel shortness of breath. This was worse when walking up and down steps, and when I laid down,  but was pretty consistent. I developed a slight cough. I felt like I could not get a great breath. I was also experiencing an irregular heart rhythm, and was monitoring my heart rate because it seemed to be fast on occasion. It felt like palpitations. This continued for a few weeks, until I contacted my doctor, who sent me to the emergency room. The ER was concerned about side effects from the vaccine, but was thinking more about blood clots. I had an EKG, CT scan, and bloodwork done. Everything was clear. However, I do feel that my symptoms match those explained related to myocarditis, and was not checked for that. My symptoms are slowly improving.
Redness irritation pain at injection site starting day after worsening on day 2..."covid arm"
Fainted. Vital signs at 3:05pm Temp 99.3 degrees F BP 132/72 RR 34 HR 60. At 3:25 Temp 98.3 degrees F BP 102/58 RR 30 HR 60.
nausea; then vomiting small amount of liquid 30 minutes after vaccination. Reports that she just found out she was pregnant yesterday; estimated gestation 5 weeks. Does not know EDD
This spontaneous report as received from the director of a health department via a company representative refers to an unspecified male patients (reported as four other female and male) of unknown age. On an unknown date the patients experienced fainting after receiving vaccination with a dose of GARDASIL (route, lot number and expiration date not reported) for prophylaxis and others unspecified shots (unspecified dose/frequency and unspecified manufacturer). The outcome of the event was unknown. This is one of several reports from the same source. Additional information has been requested.
This initial spontaneous report was received from a physician referring to a 9 weeks old male infant. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On 01-SEP-2015, at 11:33 hours the patient was vaccinated with a dose of improperly stored ROTATEQ oral solution (lot # K023157 with expiration date 23-JUL-2016, second dose; dose was not reported), that was exposed to out of normal storage temperature range. The 9 weeks old patient was vaccinated with the second dose of ROTATEQ (inappropriate schedule of vaccine administered). No adverse event was reported. Lab diagnostics test were not performed. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received.
Intense headache with no relief from ibuprofen and Tylenol (still have it) Acid reflux. No relief from over the counter medication (still have it) Dizziness (still occurring) Heart palpitations Cold chills Night sweats ( continue to today) When any part of my skin is touched anywhere in my body it feels like pins and needles Fever on the first day over 103 ( subsided within 24 hours)
After getting a pneumonia shot over 5 years after the last one, I had a fever from 101 to 103 for 5 days, muscle aches, redness & swelling of entire upper arm, nausea 5 days, then diarrhea 5 days.  Also got my annual flu shot at the same time.
Pt called covid hotline after getting her 2nd  vaccine at vaccination site on 4/10/2021. She reports the following day 4/11/2021 around 3 pm she starting having chest tightness. Pt reports she is familiar with this feeling because she has asthma. Pt reports taking her rescue inhaler and feeling better. Then today the chest tightness began again. She used her rescue inhaler but didn't have lasting relief after taking it.
On September 30,2020 I went to pharmacy. I received a flu shot from a pharmacist. The shot was high on my arm and hurt a lot. I mentioned that this was the first time a flu shot hurt like that. That night the injection site was sore and I felt pain in my shoulder. In the months following It got progressively worse. To the point I could not raise my arm up without doubling over in agony. I could not reach out for anything with my right arm. I decided to see an Orthopedic surgeon in December. I saw Dr. on December 18th 2020 he said I had locked shoulder due to inflammation possibly due to the Flu shot I had received considering that was the onset of my symptoms. I had a series of x-rays to rule out injury and there was no structural damage to my shoulder. He prescribed steroid shots and physical therapy. On December 21, 2020 I received 2 steroid shots in my shoulder. On December 23, 2020 I began physical therapy twice a week until March 9, 2021. Although the physical therapy improved my range of motion I still had pain and still have pain. I still cannot reach behind my back or into the backseat of the car or to turn off the alarm. The pain wakes me up so I don?t sleep a full night?s sleep.
No additional AE reported; The patient received one dose of GARDASIL 9, which was administered on 07AUG2019.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not provided.   On 07-AUG-2019, the patient received one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (0.5 ml, lot # 1602281 has been verified to be valid, expiration date not reported, but upon internal validation established as 21-JUL-2021; strength and route were unknown) for prophylaxis.   The patient did not complete the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) series (inappropriate schedule of product administration). No additional information was provided. No additional AE was reported. No PQC. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1602281; expirationdate: 21-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in 2018, reported as on an unspecified date since 09-JUL-2018, the patient was vaccinated with improperly stored dose of PEDVAXHIB (lot # N024570 with expiration date: 01-MAY-2020) or (lot# N024571 with expiration date: 01-MAY-2020) intramuscularly (dose and frequency were not reported) for prophylaxis. No adverse effects were reported. The vaccine was exposed to a temperature excursion of 47 to 77 degrees Fahrenheit (F) (57 degrees Fahrenheit (F)) for 14 hours. There was no previous temperature excursion. A digital data logger was involved. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1808USA007409: US-009507513-1808USA007410: US-009507513-1808USA007412: US-009507513-1808USA007413: US-009507513-1808USA007414: US-009507513-1808USA007408: US-009507513-1808USA007407: US-009507513-1808USA007406: US-009507513-1808USA007411.
Body ache; Chills; Fever; Second dose was stored incorrectly; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), CHILLS (Chills), PYREXIA (Fever) and PRODUCT STORAGE ERROR (Second dose was stored incorrectly) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced MYALGIA (Body ache), CHILLS (Chills), PYREXIA (Fever) and PRODUCT STORAGE ERROR (Second dose was stored incorrectly). On 02-Apr-2021, PRODUCT STORAGE ERROR (Second dose was stored incorrectly) had resolved. On 03-Apr-2021, MYALGIA (Body ache), CHILLS (Chills) and PYREXIA (Fever) had resolved. Not Provided          No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
23OCT2022 I started with a scratchy throat associated with fatigue and body aches also I felt feverish but temperature was normal. 24OCT2022 I felt very bad inside my whole body burning sensation feverish body aches and generally felt horrible unable to get out of bed, I thought I was going to die.
Initial report received from a health care professional (nurse) on 02 Sep 2010: This patient was vaccinated with only the lyophilized A powder component of MENVEO, (batch number not reported), (dose: unknown) intramuscularly, along with a sterile diluent. The patient did not receive the MenCWY-135 liquid component.
Sweating; shortness of breath; coughing; felt tired; soreness on site of infection; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), DYSPNOEA (shortness of breath), COUGH (coughing), FATIGUE (felt tired) and VACCINATION SITE PAIN (soreness on site of infection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Fibromyalgia.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), DYSPNOEA (shortness of breath), COUGH (coughing), FATIGUE (felt tired) and VACCINATION SITE PAIN (soreness on site of infection). At the time of the report, HYPERHIDROSIS (Sweating), DYSPNOEA (shortness of breath), FATIGUE (felt tired) and VACCINATION SITE PAIN (soreness on site of infection) outcome was unknown and COUGH (coughing) had not resolved.            NO concomitant was provided. Patient treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up  received and contains medical history, second dose date .
Patient become very dizzy after administration. Had the patient lay down on the floor for 15 minutes until he felt comfortable sitting up. At this point gave the patient some water and some crackers. Had the patient stay next to me in the room for the next half hour until he felt better.
This spontaneous report as received from a nurse practitioner refers to a 50 year old female patient with unspecified leukocytosis and diabetes. The patient's drug reactions/allergies included losartan was associated with dizziness and vancomycin was associated with a rash. On 04-FEB-2013 the patent was vaccinated subcutaneously with live ZOSTAVAX (lot # H012577, expiration date 28-SEP-2013). Concomitant therapies included JANUVIA, metformin, TOPROL, BENICAR, gabapentin, vitamin D and WELCHOL. On 06-FEB-2013 the patient present with a red, warm rash that was five inches in diameter with a small area of blisters. On 02/08/2013, the patient presented with a large red area that was seven-by-five-inches that consisted of a light red area and included a smaller area of 1.5-by-0.5-inches that was very red with multiple blisters and was painful. VALTREX was given for treatment. No laboratory diagnostics studies were performed. The outcome of the events was unknown at reporting time. The patient presented at this nurse practitioner's office for medical attention. Additional information has been requested.
Patient is a 68y.o.male h/o lung CA 2020 s/p resection, chemo and RT who was sent to HCF by Rad Onc after routine CT yesterday showed possible esophageal perforation. Seen by Thoracic Surg and underwent EGD that showed fibrinous material/ necrotic tumor in that area but no signs of perforation. He is recommended to continue with full liquid diet until f/u in 2 weeks. EGD to be repeated.
Patient presented to vaccination clinic the facility requested a Shingles vaccine for the patient. The patient presented an incorrect DOB on consent form. Upon searching database, no history of shingles vaccine was found. When billing to the patient's insurance, it was discovered that he had already had 2 previous doses of SHINGRIX.
Returned call to mom regarding immunization. Patient had immunizations 12/3. By 12/5 mom says there was an area the size of a popcan that was swollen, red and hot to the touch on her right arm. Had received the DTAP and Varicella in the right deltoid. By Sunday had doubled in size. There were treating it with cold pack. By 12/7 it was back to popcan size and she is feeling ok. Mom says there was a reaction in the past to an immunization,but she does not remember what shot nor when.
Uncontrollable vomiting (about 12 times over 8 hours) starting 2.5 days after vaccination. No one else in family is sick, no exposure to sick individuals.
This case was reported by a consumer via other manufacturer and described the occurrence of pain in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to SHINGRIX. Additional information was reported as follows: The batch number and expiry date for SHINGRIX was not reported. The age at vaccination was not reported. The patient received his dose of SHINGRIX on an unspecified date and stated that it hurt so badly that he did not want to receive the second dose of SHINGRIX. No additional information was provided. This information has not been reported to the food and drug administration (FDA).
Severe chilling,  body aches. Also headache.  Started 6:30 pm  day of vaccine.  Lasted about 36 hours.  Severe chilling lasted about 4 hours.
After vaccination patient reported dizziness. Denied further symptoms. Given juice, observed. Patient left clinic walking with guardian, reported she was "ok".
Progress Notes     1/26/2021    Patient:                                                                          Date:  1/26/2021                                                                                             a 75 y.o. female who was seen at  COVID Vaccine Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the right deltoid muscle.   During her 30 minute waiting period after the injection, the patient began to experience scratchy throat.  She denied difficulty breathing, difficulty swallowing and throat tightness.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   ALLERGY REVIEW OF SYSTEMS:  Patient denies facial swelling, chest tightness, shortness of breath, wheezing and dizziness       Previous Reactions: Patient reports a history of previous reaction after receiving an allergy shot many years ago. She is unsure of entire course of events but states she did need medical treatment including a shot.     Objective    Vitals Vitals:   01/26/21 1412 01/26/21 1439 BP: 135/78 137/63 BP Location:   Right arm Patient Position:   Sitting Pulse: 90 80 SpO2: 95% 98%     Blood Sugar 88 collected at 1415   Physical Exam Vitals signs and nursing note reviewed.  Constitutional:      General: She is not in acute distress.    Appearance: She is well-developed. She is not ill-appearing or diaphoretic.  HENT:     Head: Normocephalic and atraumatic.     Mouth/Throat:     Pharynx: Oropharynx is clear. No pharyngeal swelling or oropharyngeal exudate.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal. No tachypnea or respiratory distress.     Breath sounds: Normal breath sounds and air entry. No stridor or decreased air movement.  Skin:    General: Skin is warm and dry.  Neurological:     Mental Status: She is alert and oriented to person, place, and time.     Gait: Gait (with cane assist) normal.  Psychiatric:        Speech: Speech normal.        Behavior: Behavior normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: no therapy. Patient was observed for 65 minutes s/p injection. She states only symptom of itchy throat improved. Patient accompanied to building exit .  Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash)
took / first dose before the COVID outbreak. It made me quite ill for one day; This case was reported by a consumer and described the occurrence of unwell in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced unwell. On an unknown date, the outcome of the unwell was recovered/resolved.   It was unknown if the reporter considered the unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  After receiving 1st dose of Shingrix, the patient experienced ill for one day. The 1st dose received before the COVID outbreak. The patient was not able to receive 2nd dose of Shingrix and it was too late. The reporter consent to follow up. This case has been linked with US2020AMR248460, reported by same reporter and same patient.
This spontaneous report as received from a pharmacist via a company representative refers to a 29 year old male patient. On an unknown date, the patient was vaccinated with PNEUMOVAX 23, (lot # K009105 and expiration date 21-JAN-2016), (dose and route not reported). On 11-OCT-2014, the patient developed an injection site reaction of redness. Additionally, the arm that had received the PNEUMOVAX 23 had developed a "big red swollen shoulder". The patient went to an urgent care clinic where a nurse practitioner diagnosed him with an infection and was prescribed an antibiotic. At the time of the report the outcome of the events was unknown. This is one of several reports received from the same reproter. Additional information has been requested.
Complaining of "not feeling well" the night after the vaccination and progressively got worse in the next days to come. Patient stated that he had been having black tarry stool and after a urine dip he was identified to have blood in his urine.
I began to experience acute joint pain that progressed over a period of weeks until I finally went to my orthopedics. I got an injection in my knee that was marginally effective another consult for ankles and physical therapy.
DTaP, IPV, MMR given 9/14. 24 hours swollen, erythematous deltoid where immunization given.
Inadvertently gave FLUMIST to child < 2 yrs of age. Child is healthy with no chronic illness. Developed rash 12/12. Had fever 12/10. No other symptoms.
About five minutes after receiving vaccine, patient experienced dizziness and then syncope. She regained consciousness within seconds. Blurry vision and dizziness persisted for a few minutes then improved.
Erythema and edema to left arm between the shoulder and elbow. Arm is swollen and firm to touch. Mild pain and mild itching. Benadryl and ice used.